Vlad Ratziu
Impact in
- Hepatology top 0.02%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Liver Diseases and Immunity
- Epidemiology top 0.01%
- Liver Disease Diagnosis and Treatment
- Hepatitis B Virus Studies
Papers in
- Epidemiology 250
- Liver Disease Diagnosis and Treatment 245
- Hepatitis B Virus Studies 29
- Hepatology 106
- Hepatitis C virus research 66
- Liver Diseases and Immunity 24
- Liver Disease and Transplantation 24
- Hepatocellular Carcinoma Treatment and Prognosis 13
- Co-authors
- Thierry Poynard (103 shared papers)Frédéric Charlotte (60 shared papers)Françoise Imbert‐Bismut (41 shared papers)Arun J. Sanyal (44 shared papers)Philippe Giral (13 shared papers)M. Munteanu (74 shared papers)Yves Benhamou (27 shared papers)Ching‐Lung Lai (2 shared papers)
- Journals
- Journal of Hepatology (110 papers)Hepatology (29 papers)Gastroenterology (14 papers)Alimentary Pharmacology & Therapeutics (13 papers)Clinical Gastroenterology and Hepatology (10 papers)
- Partner nations
- FranceUnited StatesUnited Kingdom
In The Last Decade
Vlad Ratziu
329 papers receiving 25.8k citations
Vlad Ratziu's Hit Papers
Peers
Comparison fields: 5 of 167
- Hepatology 9.8k
- Epidemiology 19.7k
- Endocrinology, Diabetes and Metabolism 5.4k
- Pathology and Forensic Medicine 1.9k
- Cell Biology 1.4k
Countries citing papers authored by Vlad Ratziu
This map shows the geographic impact of Vlad Ratziu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vlad Ratziu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vlad Ratziu more than expected).
Fields of papers citing papers by Vlad Ratziu
This network shows the impact of papers produced by Vlad Ratziu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vlad Ratziu. The network helps show where Vlad Ratziu may publish in the future.
Co-authors
The 25 scholars most cited alongside Vlad Ratziu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 338 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease Hit paper breakdown → | 2005 | 1675 |
| 2 | Viral hepatitis B Hit paper breakdown → | 2003 | 1417 |
| 3 | A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis Hit paper breakdown → | 2020 | 1339 |
| 4 | Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study Hit paper breakdown → | 2001 | 1153 |
| 5 | A position statement on NAFLD/NASH based on the EASL 2009 special conference Hit paper breakdown → | 2010 | 853 |
| 6 | Liver fibrosis in overweight patients Hit paper breakdown → | 2000 | 824 |
| 7 | Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis Hit paper breakdown → | 2016 | 610 |
| 8 | Endpoints and clinical trial design for nonalcoholic steatohepatitis Hit paper breakdown → | 2011 | 603 |
| 9 | Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C Hit paper breakdown → | 2001 | 578 |
| 10 | Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial Hit paper breakdown → | 2008 | 521 |
| 11 | TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Hit paper breakdown → | 2014 | 475 |
| 12 | A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver Hit paper breakdown → | 2013 | 406 |
| 13 | 2006 | 398 | |
| 14 | 2002 | 382 | |
| 15 | 2003 | 377 | |
| 16 | 2013 | 356 | |
| 17 | Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease Hit paper breakdown → | 2014 | 356 |
| 18 | 2008 | 347 | |
| 19 | NAFLD and liver transplantation: Current burden and expected challenges Hit paper breakdown → | 2016 | 335 |
| 20 | 2009 | 308 |
About Vlad Ratziu
Vlad Ratziu is a scholar working on Epidemiology, Hepatology, Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology, having authored 338 papers that have together received 26.7k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (245 papers), Hepatitis C virus research (66 papers), Diet, Metabolism, and Disease (31 papers), Hepatitis B Virus Studies (29 papers), Liver Diseases and Immunity (24 papers), Liver Disease and Transplantation (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (13 papers) and Alcohol Consumption and Health Effects (13 papers). The work is most often cited by research in Hepatology (9.8k citations), Epidemiology (19.7k citations), Endocrinology, Diabetes and Metabolism (5.4k citations), Pathology and Forensic Medicine (1.9k citations) and Cell Biology (1.4k citations). Vlad Ratziu has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Thierry Poynard, Frédéric Charlotte, Françoise Imbert‐Bismut, Arun J. Sanyal, Philippe Giral, M. Munteanu, Yves Benhamou, Ching‐Lung Lai, Éric Bruckert and Man‐Fung Yuen. Their work appears in journals such as Journal of Hepatology, Hepatology, Gastroenterology, Alimentary Pharmacology & Therapeutics and Clinical Gastroenterology and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.